Filing Details

Accession Number:
0001209191-14-072924
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-03 21:24:22
Reporting Period:
2014-12-01
Filing Date:
2014-12-03
Accepted Time:
2014-12-03 21:24:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1272354 Ron Cohen 420 Saw Mill River Road
Ardsley NY 10502
President And Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-01 51,265 $8.14 529,794 No 4 M Direct
Common Stock Disposition 2014-12-01 34,394 $35.59 495,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2014-12-01 51,265 $0.00 51,265 $8.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-01-01 No 4 M Direct
Footnotes
  1. Exercise and sales pursuant to a 10b5-1 plan. Dr. Cohen exercised 51,265 stock options, all of which were due to expire 1/1/2015 unless exercised. Dr. Cohen sold 19,200 of the resultant shares, the proceeds of which are being used to fund the exercise of the options and the resulting tax liability. In addition, Dr. Cohen vested in 30,384 shares of restricted stock of which he sold 15,194 shares, the proceeds of which are being used to fund the resulting tax liability. A record of all of Dr. Cohen's holdings is available in Acorda's SEC filings. Dr. Cohen retains the majority of the equity he has been granted in the Company since founding Acorda in 1995.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.27 to $36.27 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The shares subject to these options vested in installments and were fully vested on 3/01/2009.